Catalyst Wire Dossier Catalyst Wire Dossier

ZYG24002 Lotion

· Sinomune Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZYG24002 Lotion, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis [Phase 1]

See pricing